These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3030894)

  • 1. Development of an amphotropic, high-titer retrovirus vector expressing the dihydrofolate reductase gene and conferring methotrexate resistance.
    Narayanan R; Jastreboff MM; Bertino JR
    Gene; 1986; 48(1):71-80. PubMed ID: 3030894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.
    Miller AD; Law MF; Verma IM
    Mol Cell Biol; 1985 Mar; 5(3):431-7. PubMed ID: 2985952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.
    Williams DA; Hsieh K; DeSilva A; Mulligan RC
    J Exp Med; 1987 Jul; 166(1):210-8. PubMed ID: 3298524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
    Li M; Hantzopoulos PA; Banerjee D; Zhao SC; Schweitzer BI; Gilboa E; Bertino JR
    Hum Gene Ther; 1992 Aug; 3(4):381-90. PubMed ID: 1525211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
    Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient protection from methotrexate toxicity and selection of transduced human hematopoietic cells following gene transfer of dihydrofolate reductase mutants.
    Meisel R; Bardenheuer W; Strehblow C; Sorg UR; Elmaagacli A; Seeber S; Flasshove M; Moritz T
    Exp Hematol; 2003 Dec; 31(12):1215-22. PubMed ID: 14662327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate.
    Lo KM; Lynch CA; Gillies SD
    Gene; 1992 Nov; 121(2):365-9. PubMed ID: 1446834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.
    Stuhlmann H; Jaenisch R; Mulligan RC
    Mol Cell Biol; 1989 Jan; 9(1):100-8. PubMed ID: 2927389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
    Zhao SC; Li MX; Banerjee D; Schweitzer BI; Mineishi S; Gilboa E; Bertino JR
    Cancer Gene Ther; 1994 Mar; 1(1):27-33. PubMed ID: 7621235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
    Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
    Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a dominant selectable marker using a novel dihydrofolate reductase.
    Hussain A; Lewis D; Yu M; Melera PW
    Gene; 1992 Mar; 112(2):179-88. PubMed ID: 1555767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance.
    Morris JA; McIvor RS
    Biochem Pharmacol; 1994 Mar; 47(7):1207-20. PubMed ID: 8161350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells.
    McIvor RS; Simonsen CC
    Nucleic Acids Res; 1990 Dec; 18(23):7025-32. PubMed ID: 2263462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of high-expressing cells by methotrexate amplification of destabilized dihydrofolate reductase selection marker.
    Ng SK
    Methods Mol Biol; 2012; 801():161-72. PubMed ID: 21987253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil.
    Capiaux GM; Budak-Alpdogan T; Takebe N; Mayer-Kuckuk P; Banerjee D; Maley F; Bertino JR
    Hum Gene Ther; 2003 Mar; 14(5):435-46. PubMed ID: 12691609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
    Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K
    Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
    Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
    Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.